Ingestible sensors are tiny edible devices that are swallowed and pass through the gastrointestinal tract, relaying information about pH levels, temperature and pressure within the digestive system. They provide useful insights regarding digestion, medication adherence and gastrointestinal disorders. Ingestible sensors work without the need for deployment of endoscopic techniques and can be conveniently used for continuous monitoring from the comfort of home over extended periods of time. These miniature ingestible devices equipped with miniaturized sensors are propelled by natural movement within the GI tract and transmit motility and pH information externally to a data recorder or smartphone via LoRa, Bluetooth or Wi-Fi.

The global ingestible sensors market is estimated to be valued at US$ 1,583.2 Mn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the ingestible sensors market are CapsoVision, Inc., BodyCAP, etectRx, Koninklijke Philips N.V., Medtronic, Otsuka Holdings Co., Ltd., IntroMedic, JIHNSAN Science & Technology, Check-Cap, Proteus Digital Health Inc., and HQ, Inc. The ingestible sensors market is driven by the growing demand for non-invasive monitoring solutions and remote patient monitoring. With increasing prevalence of gastrointestinal disorders as well as growing need for continuous monitoring in applications such as drug delivery and medication adherence, the ingestible sensors market is witnessing significant expansion globally. Key players are investing in R&D to develop advanced technologies and novel ingestible sensor platforms with miniaturized components for improved performance and accurate data transmission.

The growing demand for non-invasive monitoring solutions is a key factor contributing to the growth of the Ingestible Sensors Market Size. Non-invasive monitoring is preferred over traditional endoscopic procedures which are costly and uncomfortable for patients. Ingestible sensors enable continuous physiological monitoring from the comfort of home without any patient discomfort. There is a growing demand for such remote patient monitoring solutions to efficiently manage chronic conditions.

The global ingestible sensors market is witnessing significant expansion supported by increasing research and development activities. Key market players are focusing on various geographical regions to strengthen their presence. North America dominated the ingestible sensors market in 2024 followed by Europe. However, Asia Pacific is expected to exhibit fastest growth during the forecast period with growing healthcare expenditure and increasing awareness.

Market drivers

The primary driver for the ingestible sensors market is the increasing need for remote monitoring capabilities. Ingestible sensors allow continuous physiological monitoring from a remote location without requiring hospitalization or clinic visits. This is advantageous for vulnerable patient groups such as geriatrics and paediatric patients. It also enables monitoring of post-surgical patients and medication adherence on an out-patient basis. The remote monitoring capability of ingestible sensors improves healthcare access, outcomes and reduces costs associated with traditional in-patient care.